Douglas V Faller Selected Research

arginine butyrate

1/2012	Histone deacetylase inhibitors are potent inducers of gene expression in latent EBV and sensitize lymphoma cells to nucleoside antiviral agents.
12/2010	A randomized phase II trial of Arginine Butyrate with standard local therapy in refractory sickle cell leg ulcers.
3/2007	A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies.
3/2006	Fas ligand-mediated lethal hepatitis after rapid lysis of a localized natural killer cell lymphoma.
4/2002	Differential effects of short-chain fatty acids on head and neck squamous carcinoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Douglas V Faller Research Topics

Disease

42	Neoplasms (Cancer) 05/2022 - 04/2002
9	Hemoglobinopathies 01/2016 - 12/2002
8	Prostatic Neoplasms (Prostate Cancer) 10/2013 - 08/2007
6	Anemia 07/2021 - 12/2002
6	Lymphoma (Lymphomas) 01/2012 - 03/2006
5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2022 - 01/2018
5	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 06/2015
5	Breast Neoplasms (Breast Cancer) 03/2013 - 06/2004
4	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 11/2022 - 01/2018
4	Thalassemia 04/2014 - 08/2011
3	Immunoglobulin Light-chain Amyloidosis 01/2022 - 01/2017
3	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2022 - 01/2018
3	Melanoma (Melanoma, Malignant) 09/2015 - 02/2014
3	Sickle Cell Anemia (Hemoglobin S Disease) 04/2014 - 08/2011
3	beta-Thalassemia (Cooley's Anemia) 08/2011 - 09/2005
2	Febrile Neutropenia 01/2022 - 01/2019
2	Nausea 01/2022 - 01/2019
2	Stomatitis 01/2022 - 01/2022
2	Eye Diseases (Eye Disease) 01/2022 - 01/2017
2	Infections 01/2018 - 01/2017
2	Virus Diseases (Viral Diseases) 01/2017 - 04/2009
2	Pancreatic Neoplasms (Pancreatic Cancer) 05/2014 - 06/2012
2	Leukemia 04/2009 - 05/2003
2	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2009 - 02/2002
2	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2007 - 11/2002
2	Carcinogenesis 06/2003 - 05/2003
1	Hyperglycemia 01/2022
1	Retinal Degeneration 01/2022
1	Fatigue 07/2021
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 04/2021
1	Hematologic Neoplasms (Hematological Malignancy) 01/2021
1	Rare Diseases (Rare Disease) 01/2021
1	Endometrial Neoplasms (Endometrial Cancer) 11/2020
1	Renal Cell Carcinoma (Grawitz Tumor) 11/2020
1	Urinary Bladder Neoplasms (Bladder Cancer) 11/2020
1	Central Nervous System Diseases (CNS Diseases) 01/2020

Drug/Important Bio-Agent (IBA)

8	EnzymesIBA 11/2022 - 06/2003
8	GlobinsIBA 01/2016 - 01/2005
8	Proteins (Proteins, Gene)FDA Link 02/2014 - 02/2004
7	pevonedistatIBA 11/2022 - 01/2018
7	Butyrates (Butyrate)IBA 06/2015 - 06/2003
7	Histone Deacetylases (Histone Deacetylase)IBA 11/2014 - 06/2003
6	Histone Deacetylase InhibitorsIBA 01/2016 - 11/2002
6	Sirtuin 1IBA 01/2015 - 08/2007
6	DNA (Deoxyribonucleic Acid)IBA 10/2013 - 01/2007
5	Biological ProductsIBA 03/2016 - 04/2002
5	gamma-GlobinsIBA 04/2014 - 12/2002
5	arginine butyrateIBA 01/2012 - 04/2002
4	Azacitidine (5 Azacytidine)FDA Link 11/2022 - 11/2019
4	Pharmaceutical PreparationsIBA 01/2019 - 07/2009
4	Antiviral Agents (Antivirals)IBA 01/2017 - 01/2007
4	Small Interfering RNA (siRNA)IBA 04/2014 - 08/2007
4	OligonucleotidesIBA 06/2013 - 04/2008
4	Androgen Antagonists (Antiandrogens)IBA 03/2013 - 08/2007
4	Ganciclovir (Cytovene)FDA LinkGeneric 01/2012 - 03/2006
4	ProhibitinsIBA 09/2008 - 06/2002
4	Volatile Fatty AcidsIBA 05/2006 - 04/2002
3	sapanisertibIBA 05/2022 - 11/2020
3	Thioctic Acid (Lipoic Acid)IBA 01/2022 - 04/2002
3	Protein Kinases (Protein Kinase)IBA 04/2021 - 12/2011
3	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 01/2021 - 01/2019
3	AntioxidantsIBA 01/2017 - 06/2015
3	Fetal Hemoglobin (Hemoglobin F)IBA 04/2014 - 08/2011
3	Phosphotransferases (Kinase)IBA 10/2013 - 02/2004
3	AndrogensIBA 03/2013 - 08/2007
3	Androgen Receptors (Androgen Receptor)IBA 03/2013 - 02/2008
3	NucleosidesIBA 01/2012 - 01/2007
3	Cyclin AIBA 12/2010 - 02/2004
3	Estrogen AntagonistsIBA 12/2009 - 06/2004
3	ChromatinIBA 11/2006 - 06/2003
2	Gemcitabine FDA Link 11/2019 - 01/2019
2	Carboplatin (JM8)FDA LinkGeneric 11/2019 - 01/2019
2	Paclitaxel (Taxol)FDA LinkGeneric 11/2019 - 01/2019
2	Docetaxel (Taxotere)FDA Link 11/2019 - 01/2019
2	Protein Isoforms (Isoforms)IBA 01/2019 - 07/2009
2	alpha-GlobinsIBA 04/2014 - 08/2010
2	LigandsIBA 06/2013 - 03/2013
2	Estrogen ReceptorsIBA 03/2013 - 02/2008
2	Telomerase (Telomerase Reverse Transcriptase)IBA 08/2012 - 04/2008
2	Vorinostat FDA Link 01/2012 - 09/2011
2	Therapeutic UsesIBA 12/2010 - 05/2006
2	Thymidine KinaseIBA 03/2007 - 01/2007
2	Histone Acetyltransferases (Histone Acetyltransferase)IBA 02/2004 - 06/2003
1	ProdrugsIBA 01/2022
1	Retinaldehyde (Retinal)IBA 01/2022
1	Alkaline PhosphataseIBA 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022
1	Carnitine (L-Carnitine)FDA LinkGeneric 01/2022
1	MLN 8237IBA 01/2022
1	Thalidomide (Thalomid)FDA Link 01/2022
1	ixazomibIBA 01/2022
1	Lenalidomide (CC 5013)FDA Link 01/2022
1	SolutionsIBA 07/2021
1	Tyrosine Kinase InhibitorsIBA 04/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 11/2020
1	Amyloid (Amyloid Fibrils)IBA 07/2019

Therapy/Procedure

17	Therapeutics 01/2020 - 06/2003
4	Drug Therapy (Chemotherapy) 01/2019 - 01/2017
1	Investigational Therapies (Experimental Therapy) 01/2021